About me
Miriam Jacobs, MD, is board-certified and fellowship-trained in medical oncology at MedStar Georgetown Cancer Institute at MedStar Georgetown University Hospital. As a specialist in early and advanced breast cancers, Dr. Jacobs provides chemotherapy, hormone therapy, immunotherapy, precision medicine, and clinical trials. She is also a member of the American Association of Cancer Research, the American Society of Hematology, and the American Society of Clinical Oncology.
Dr. Jacobs’ approach to care focuses on providing individualized and holistic treatments. She begins by talking with patients to learn about their medical histories and health goals. She then collaborates with an experienced team of radiation oncologists and surgeons to develop comprehensive and tailored wellness plans. She also educates patients about natural, traditional, and state-of-the-art cancer treatments.
Dr. Jacobs is dedicated to advancing the field of precision medicine – an innovative form of care that uses people’s own cells to develop highly personalized prevention, diagnosis, and treatment options. She is particularly interested in providing hormone receptor-positive, CAR T-cell, and CAR NK-cell therapies to improve the health of breast cancer survivors. Referring physicians should know that she is available to give second opinions and discuss clinical trial opportunities.
Philosophy of care
“Research creates endless possibilities to discover new methods of treating complex diseases or enhancing people’s lives. As a clinical researcher, I’m passionate about contributing to the collection of knowledge that can lead to immediate medical solutions or future health innovations. I’m also grateful to clinical trial participants who are true healthcare pioneers and heroes.”
About the MedStar Georgetown Cancer Institute
MedStar Georgetown is part of the MedStar Georgetown Cancer Institute, which combines medical expertise, the latest therapies, and research across MedStar Health. Our research engine, the Georgetown Lombardi Comprehensive Cancer Center, is the only National Cancer Institute-designated comprehensive cancer center in the Washington, D.C., region. This partnership means we provide access to cutting-edge clinical trials and the latest breakthroughs in cancer care.
Clinical areas of focus
- Breast Cancer
- HER2 Positive Breast Cancer
- Hormone Receptor Positive Breast Cancer
- Metastatic Breast Cancer
- Triple Negative Breast Cancer
Conditions and procedures
Conditions I treat
- Abnormal Mammogram
- Adolescent And Young Adult Cancer (AYA)
- Atm Mutation
- Atypical Ductal Hyperplasia
- Atypical Lobular Hyperplasia
- Axillary Lymphadenopathy
- Breast Cancer
- HER2 Positive Breast Cancer
- Hormone Receptor Positive Breast Cancer
- Metastatic Breast Cancer
- Triple Negative Breast Cancer
Procedures I perform
- Adjuvant Chemotherapy
- Adjuvant Chemotherapy
- Adjuvant Radiation Therapy
- Areola Sparing Mastectomy
- Aromatase Inhibitor
Practice locations
Distance from Change LocationEnter your Location
3800 Reservoir Road Northwest Lombardi Cancer Center Washington, DC, 20007
202-444-2223Fax 202-444-1229
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Aetna Open Choice (PPO)
- Aetna Medicare Advantage HMO & PPO Plans
- Innovation Health: Open POS Plus
- Innovation Health: Open POS II
- Aetna Managed Choice Open Access (POS)
- Aetna Choice POS & Choice POS II
- Innovation Health: POS Plus
- Aetna Managed Choice (POS)
- Innovation Health: POS
- Aetna Open HMO/Open HMO Option/Open EPO Plus
- Aetna HMO-Open Access/Select OA
- Aetna HealthFund/Health Network Option OA
- Innovation Health: HMO & EPO Plus
- Aetna Select HMO/HealthFund/Health Network
- Aetna HMO
- Innovation Health: Open Network Only Plus
- Aetna Elect Choice/ Open Access (POS)
- Innovation Health: Network Only Plus
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- Cigna TotalCare (HMO D-SNP)
- Cigna Preferred Medicare
- Cigna Alliance Medicare (HMO) |
- Cigna Achieve Medicare (HMO C-SNP)
- Veterans Affairs Community Care Network (VA CCN)
- United Medicare Advantage DSNP District of Columbia
- United Student Resources
- United Select Plus (POS)
- United Select HMO - EPO/NPP
- United Options (PPO) (includes Empire PPO)
- United Golden Rule
- United GEHA (for all other states) Compass Rose
- D-SNP)
- I-SNP
- United Nursing Home Plan (C-SNP
- United Erickson Advantage Plans
- United Choice Plus
- United Choice
- United Mamsi Life & Health
- MedStar Family Choice DC Healthy Families
- MedStar Family Choice DC Healthcare Alliance
- United MD IPA Preferred (POS)
- United MD IPA (HMO)
- Kaiser Permanente Signature-Added Choice
- Kaiser Signature
- Kaiser HMO Plus and DHMO Plus Member
- Kaiser Select-Added Choice
- Kaiser Select
- Kaiser Medicare Plus
- Kaiser Medicare Advantage Signature and Select
- Kaiser Flexible Choice
- Kaiser Maryland Medicaid MCO
- HumanaChoice PPO
- HumanaChoice Honor’s plan PPO
- Health Services for Children with Special Needs (HSCSN)
- Cigna True Choice Plus Medicare (PPO)
- Cigna True Choice Medicare (PPO)
- Cigna POS/Network POS
- Cigna Indemnity
- Cigna POS Open Access & Open Access Plus
- Cigna Network Open Access
- Cigna HMO Open Access
- Cigna PPO and PPO Plus
- Cigna EPO
- Cigna Choice Fund PPO
- Choice Care Network/HUMANA (PPO)
- Beech Street PPO
- Anthem Plus BCBS of VA HealthKeepers Plus
- Anthem (POS & Open Access POS) BCBS of VA HealthKeepers
- Anthem HMO - BCBS of VA HealthKeepers
- Innovation Health: Indemnity
- Aetna Traditional Choice (PPO)
- Aetna Student Health Insurance
- Aetna Signature Administrator PPO/TPA
- Aetna Quality Point of Service (POS)
- Innovation Health: PPO
- Cigna HMO & Network (HMO)
- WellPoint Maryland - Maryland Health Choice
- WellPoint Maryland
- Virginia Premier
- Veterans Affairs Community Care Network
- UnitedHealthcare Individual Exchange Plans
- United Community Plan - Maryland Health Choice Program
- Private Health Care Systems (PHCS) (PPO)
- Police and Fire Clinic
- United Optimum Choice Preferred (POS) & OCI Direct (HMO)
- United Optimum Choice
- United Navigate
- United Core Essential (HMO)
- United Group Medicare Advantage Plans
- United AARP Medicare Complete
- Traditional Medicare Fee for Service
- Medicaid - Virginia
- Medicaid - Maryland
- Medicaid - District of Columbia
- Tricare for Life East
- Tricare Reserve Select
- Tricare East Select
- Tricare East Prime
- Maryland Point of Service Plan (MPOS)
- HealthyBlue PPO
- Federal Employee Program (Std/Basic PPO/Blue Focus)
- CareFirst NASCO
- CareFirst MedStar Select PPO
- CareFirst MedStar PPO
- CareFirst Maryland Indemnity or PPO
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- CareFirst Group Medicare Advantage
- CareFirst BC/BS Advantage Core/Enhanced
- CareFirst Blue Card Program (Out-of-area BCBS plans)
- CareFirst Administrators
- CareFirst (NCA) Indemnity
- Carefirst BlueChoice Opt Out Plus Open Access (POS)
- Carefirst Healthy Blue (HMO/POS)
- Carefirst BlueChoice Opt Out Open Access
- Carefirst BlueChoice Open Access
- Carefirst BlueChoice HMO
- Carefirst EPO
- Carefirst Blue Preferred PPO
- MedStar Family Choice - Maryland Health Choice
- First Health PPO
- Coventry of Delaware HMO/PPO
- Coventry Health Care of Virginia
- Coventry Health Care National Network PPO
- Great-West Healthcare POS/CIGNA
Videos
Education
Board Certification: American Board of Internal Medicine, Internal Medicine
Board Certification: American Board of Internal Medicine, Medical Oncology
Fellowship Program: Washington University/Barnes Jewish Hospital (2021)
Residency Program: University of California San Diego (2015)
Medical School: Ben Gurion University (2012)
Awards
- Abstract Achievement Award, American Society of Hematology (December 2019) Dean’s Scholar Award, Washington University School of Medicine (July 2022-Present)
Hospital affiliations
News and publications
A Noncompetitive Inhibitor of Serotonin Transport, Acts by Stabilizing the Cytoplasmic-Facing Form of the Transporter, Journal of Biological Chemistry, August 2007
A Conformational Mechanism for Neurotransmitter Transporters, Proceedings of the National Academy of Sciences, July 2008
A Conserved Asparagine Residue in TM1 of the Serotonin Transporter Dictates Chloride-Coupled Neurotransmitter Transport, Journal of Biological Chemistry, July 2011
Use of Low Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small Cell Lung Cancer, JCO Precision Oncology, 2018
Genomic Landscape of Appendiceal Neoplasms, JCO Precision Oncology, 2018
The Use of Ruxolitinib for Acute Graft-Versus Host Disease Developing After Solid Organ Transplantation, American Journal of Transplantation, February 2020
Outcomes of Patients with Large B-Cell Lymphoma Progressing After Axicabtagene Cilolecuel Therapy, Blood, April 1, 2021
Memory-Like Differentiation Enhances NK Cell Response to Melanoma, Clinical Cancer Research, August 3, 2021
CD7 Deleted Hematopoietic Stem Cells Can Restore Immunity After CAR T-Cell Therapy, Journal of Clinical Investigation Insights, August 23, 2021
Systemic IL-15 Promotes Allogeneic Cell Rejection in Patients Treated with Natural Killer Cell Adoptive Therapy, Blood, February 24, 2022
Hematopoietic Cell Transplantation Donor-Derived Memory-Like NK Cells Functionally Persist After Transfer Into Patients with Leukemia, Science Translational Medicine, February 23, 2022
Severity of Cytokine Release Syndrome Influences Outcomes After Axicabtagene Ciloleucel for Large B Cell Lymphoma, Clinical Lymphoma Myeloma and Leukemia, October 22, 2022
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice, Journal of Clinical Oncology, December 2022